The budget impact of using enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg to prevent recurrent cardiovascular events.

about

The budget impact of using enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg to prevent recurrent cardiovascular events.

Item

http://www.wikidata.org/entity/Q38987249

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

The budget impact of using ent ...... current cardiovascular events.

@en

type

Item

label

The budget impact of using ent ...... current cardiovascular events.

@en

prefLabel

The budget impact of using ent ...... current cardiovascular events.

@en

P1476

The budget impact of using ent ...... current cardiovascular events.

@en

P2093

David Schofield

http://www.w3.org/2001/XMLSchema#string

James P Tursi

http://www.w3.org/2001/XMLSchema#string

John G Fort

http://www.w3.org/2001/XMLSchema#string

Wenjie Zhang

http://www.w3.org/2001/XMLSchema#string

Yi Han

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association

Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations

Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.

Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies

Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin

Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease

Impact of medication therapy discontinuation on mortality after myocardial infarction

A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease

Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

P304

592-598

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13696998.2017.1289940

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28145783

http://www.w3.org/2001/XMLSchema#string